Aquaculture · Founded 2012 · www.apexfrozenfoods.in · BSE 540692 · NSE APEX · ISIN INE346W01013
No Notes Added Yet
Business
Apex Frozen Foods Ltd. is an integrated producer and exporter of high-quality frozen shrimp. The company's core business involves aquaculture farming (primarily Vannamei shrimp), processing, and exporting a diverse range of value-added frozen shrimp products. They operate a fully integrated supply chain, from hatchery and farming to advanced processing facilities. Apex primarily caters to the international market, supplying directly to retailers, food service companies, and distributors in key regions such as the United States and Europe. The company makes money by processing raw shrimp into various forms (e.g., Head-On, Headless, Peeled, P&D - Peeled & Deveined) and exporting them to meet global consumer demand for seafood.
Revenue Mix
Apex Frozen Foods Ltd. primarily operates as a single business segment: the production and export of frozen shrimp. The company's revenue is largely derived from the sale of different forms of Vannamei shrimp products. While specific revenue breakdown by product form (e.g., headless, peeled, P&D) or geographical contribution isn't always granularly disclosed, the United States typically represents a significant portion of its export revenues, followed by European markets. The company's focus remains on expanding its market reach and product offerings within the frozen shrimp category.
Industry
Apex Frozen Foods operates within the global aquaculture sector, specifically in shrimp farming and processing. India is one of the leading global exporters of shrimp, making the industry highly competitive with numerous domestic and international players. Apex is positioned as a mid-sized to large player within the Indian context, known for its integrated operations and focus on quality and international certifications (e.g., BRC, BAP, ASC). Its positioning is strengthened by direct long-term relationships with major international buyers and its ability to meet stringent quality and safety standards required by developed markets.
MOAT
Apex Frozen Foods' competitive advantages are primarily derived from:
Integrated Operations: Controlling the supply chain from hatchery to processing provides better quality control, traceability, and potential cost efficiencies compared to non-integrated players.
Established Export Relationships: Long-standing direct relationships with key retailers and food service companies in major consuming markets (USA, Europe) act as a strong barrier to entry for new competitors.
Quality Certifications: Adherence to global food safety and quality standards (e.g., BAP, BRC, ASC) is crucial for export and builds trust with international buyers, differentiating it from less compliant competitors.
Operational Scale & Efficiency: While not the largest global player, its operational scale in processing allows for certain cost efficiencies and the ability to fulfill large orders.
Growth Drivers
Key factors that can drive Apex's growth over the next 3-5 years include:
Rising Global Demand for Seafood: Increasing health consciousness and population growth are driving higher per capita consumption of protein, particularly seafood like shrimp.
Shift to Aquaculture: Depletion of wild-catch fisheries is leading to a greater reliance on farmed seafood, providing a structural tailwind for aquaculture companies.
Capacity Expansion: Strategic investments in increasing processing capacity or farming area can boost production volumes.
Market Penetration & Diversification: Expanding presence in existing markets or entering new geographies, as well as introducing new value-added products, can drive growth.
Traceability and Sustainability Trends: Growing consumer preference for sustainably sourced and traceable seafood benefits companies with integrated and certified operations.
Risks
Apex Frozen Foods faces several key business risks:
Disease Outbreaks: Shrimp farming is highly susceptible to diseases like White Spot Syndrome Virus (WSSV) or Early Mortality Syndrome (EMS), which can devastate harvests and impact profitability.
Commodity Price Volatility: Global shrimp prices are subject to supply-demand dynamics, which can fluctuate significantly, impacting revenue and margins.
Trade Barriers & Regulations: Anti-dumping duties, countervailing duties, import restrictions, and stringent regulatory changes in key export markets (e.g., USA, EU) pose significant risks.
Currency Fluctuations: As an exporter, the company is exposed to currency exchange rate volatility, particularly between the Indian Rupee and the US Dollar.
Input Cost Inflation: Rising costs of feed, labor, energy, and logistics can compress margins.
Intense Competition: The global shrimp market is highly competitive, with players from countries like Ecuador, Vietnam, and Indonesia constantly vying for market share.
Management & Ownership
Apex Frozen Foods Ltd. is primarily promoted by Mr. Karuturi Satyanarayana Murty, who has been instrumental in the company's growth and operations. The company has a professional management team with experience in the aquaculture and seafood processing industry. Promoter holding typically constitutes a significant majority of the shares, indicating strong insider alignment. Institutional and public shareholders hold the remaining stake.
Outlook
Apex Frozen Foods benefits from its integrated operations and established presence in key international markets, positioning it to capitalize on the growing global demand for shrimp. The company's focus on quality certifications and direct relationships with buyers provides a degree of stability in its export business. However, the business operates in a highly cyclical and risk-prone industry. Vulnerabilities to disease outbreaks in shrimp farms, volatile commodity prices, potential trade barriers, and currency fluctuations are constant challenges. While the long-term trend for aquaculture demand remains positive, Apex's performance will heavily depend on managing these external risks effectively and sustaining its operational efficiencies.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 162 | 186 | 200 | 231 | 197 | 258 | 238 | 264 | 168 | 257 |
| Other Income | 1 | 0 | 1 | 2 | 1 | 3 | 6 | 4 | 4 | 3 |
| Total Income | 163 | 186 | 200 | 233 | 198 | 261 | 245 | 268 | 172 | 259 |
| Total Expenditure | 160 | 175 | 196 | 227 | 191 | 243 | 227 | 251 | 155 | 226 |
| Operating Profit | 3 | 11 | 5 | 6 | 8 | 18 | 18 | 17 | 17 | 33 |
| Interest | 2 | 2 | 3 | 3 | 1 | 2 | 1 | 1 | 1 | 0 |
| Depreciation | 1 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 5 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 |
| Profit Before Tax | -0 | 5 | -2 | -0 | 3 | 13 | 16 | 13 | 11 | 29 |
| Provision for Tax | -0 | 1 | -0 | 0 | 1 | 4 | 4 | 3 | 3 | 7 |
| Profit After Tax | -0 | 4 | -2 | -0 | 2 | 9 | 12 | 10 | 8 | 22 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -0 | 4 | -2 | -0 | 2 | 9 | 12 | 10 | 8 | 22 |
| Adjusted Earnings Per Share | -0.1 | 1.2 | -0.5 | -0.1 | 0.6 | 2.9 | 3.8 | 3.2 | 2.5 | 6.9 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 604 | 699 | 999 | 875 | 827 | 818 | 926 | 1070 | 804 | 814 | 931 | 927 |
| Other Income | 5 | 11 | 20 | 22 | 19 | 8 | 6 | 2 | 3 | 5 | 17 | 17 |
| Total Income | 608 | 709 | 1019 | 896 | 846 | 826 | 932 | 1072 | 807 | 818 | 948 | 944 |
| Total Expenditure | 563 | 654 | 889 | 785 | 740 | 728 | 840 | 987 | 764 | 788 | 876 | 859 |
| Operating Profit | 45 | 55 | 130 | 111 | 106 | 98 | 92 | 85 | 44 | 30 | 73 | 85 |
| Interest | 10 | 11 | 9 | 7 | 11 | 16 | 17 | 15 | 9 | 9 | 4 | 3 |
| Depreciation | 5 | 6 | 9 | 11 | 15 | 22 | 19 | 19 | 15 | 15 | 15 | 16 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Profit Before Tax | 30 | 37 | 113 | 94 | 81 | 61 | 56 | 51 | 20 | 6 | 53 | 69 |
| Provision for Tax | 10 | 12 | 33 | 33 | 20 | 16 | 15 | 15 | 5 | 2 | 14 | 17 |
| Profit After Tax | 19 | 25 | 79 | 61 | 61 | 44 | 41 | 36 | 15 | 4 | 39 | 52 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 19 | 25 | 79 | 61 | 61 | 44 | 41 | 36 | 15 | 4 | 39 | 52 |
| Adjusted Earnings Per Share | 0 | 0 | 25.3 | 19.5 | 19.4 | 14.2 | 13.1 | 11.5 | 4.7 | 1.2 | 12.4 | 16.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 14% | -5% | 3% | 4% |
| Operating Profit CAGR | 143% | -5% | -6% | 5% |
| PAT CAGR | 875% | 3% | -2% | 7% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 44% | 13% | 2% | NA% |
| ROE Average | 8% | 4% | 6% | 15% |
| ROCE Average | 10% | 6% | 8% | 17% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 75 | 109 | 302 | 355 | 396 | 440 | 468 | 490 | 497 | 494 | 528 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 12 | 21 | 8 | 7 | 24 | 28 | 29 | 3 | 7 | 6 | 2 |
| Other Non-Current Liabilities | 1 | 6 | -2 | -1 | -3 | -2 | 6 | 7 | 8 | 9 | 10 |
| Total Current Liabilities | 90 | 140 | 119 | 145 | 206 | 189 | 174 | 114 | 121 | 104 | 53 |
| Total Liabilities | 179 | 277 | 428 | 507 | 623 | 654 | 678 | 614 | 633 | 613 | 593 |
| Fixed Assets | 55 | 83 | 111 | 115 | 280 | 250 | 236 | 242 | 254 | 243 | 239 |
| Other Non-Current Assets | 8 | 3 | 26 | 128 | 8 | 18 | 30 | 38 | 16 | 16 | 36 |
| Total Current Assets | 116 | 191 | 290 | 264 | 335 | 386 | 412 | 334 | 363 | 354 | 318 |
| Total Assets | 179 | 277 | 428 | 507 | 623 | 654 | 678 | 614 | 633 | 613 | 593 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 2 | 5 | 64 | 7 | 7 | 3 | 1 | 2 | 3 | 2 |
| Cash Flow from Operating Activities | 37 | 14 | 33 | 49 | 58 | 13 | 36 | 121 | 11 | 54 | 96 |
| Cash Flow from Investing Activities | -16 | -29 | -58 | -114 | -44 | -14 | -10 | -22 | -8 | -6 | -2 |
| Cash Flow from Financing Activities | -21 | 17 | 85 | 7 | -14 | 4 | -27 | -99 | -2 | -49 | -78 |
| Net Cash Inflow / Outflow | 0 | 3 | 60 | -58 | 1 | 3 | -2 | 1 | 1 | -1 | 16 |
| Closing Cash & Cash Equivalent | 1 | 5 | 64 | 7 | 7 | 10 | 1 | 2 | 3 | 2 | 18 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0 | 0 | 25.31 | 19.45 | 19.41 | 14.17 | 13.14 | 11.48 | 4.67 | 1.24 | 12.43 |
| CEPS(Rs) | 10.09 | 13.08 | 28.08 | 22.93 | 24.08 | 21.19 | 19.07 | 17.7 | 9.41 | 6.15 | 17.35 |
| DPS(Rs) | 0 | 1 | 2 | 2 | 2 | 2 | 2.5 | 2.5 | 2 | 2 | 2.5 |
| Book NAV/Share(Rs) | 0 | 0 | 96.74 | 113.63 | 126.68 | 140.74 | 149.9 | 156.79 | 159.06 | 158.23 | 168.96 |
| Core EBITDA Margin(%) | 6.69 | 6.35 | 11.02 | 10.24 | 10.52 | 11.11 | 9.32 | 7.76 | 5.01 | 3.09 | 5.94 |
| EBIT Margin(%) | 6.66 | 6.96 | 12.14 | 11.46 | 11.05 | 9.35 | 7.95 | 6.1 | 3.58 | 1.77 | 6.15 |
| Pre Tax Margin(%) | 4.93 | 5.36 | 11.27 | 10.71 | 9.76 | 7.4 | 6.07 | 4.73 | 2.43 | 0.69 | 5.67 |
| PAT Margin (%) | 3.19 | 3.6 | 7.92 | 6.95 | 7.33 | 5.41 | 4.43 | 3.35 | 1.81 | 0.48 | 4.16 |
| Cash Profit Margin (%) | 4.01 | 4.49 | 8.79 | 8.19 | 9.1 | 8.09 | 6.43 | 5.17 | 3.65 | 2.36 | 5.8 |
| ROA(%) | 11.21 | 11.03 | 22.46 | 13.02 | 10.74 | 6.93 | 6.17 | 5.55 | 2.34 | 0.62 | 6.44 |
| ROE(%) | 29.38 | 27.21 | 38.42 | 18.5 | 16.15 | 10.6 | 9.04 | 7.49 | 2.96 | 0.78 | 7.6 |
| ROCE(%) | 26.72 | 26.02 | 39.93 | 23.56 | 18.16 | 13.29 | 11.84 | 10.75 | 4.88 | 2.46 | 10.45 |
| Receivable days | 27.72 | 32.46 | 27.45 | 33.58 | 38.1 | 51.2 | 55.67 | 41.63 | 49.58 | 52.41 | 45.98 |
| Inventory Days | 33.23 | 32.24 | 30.23 | 43.37 | 64.06 | 76.98 | 71.73 | 64.92 | 84.18 | 85.5 | 69.13 |
| Payable days | 11.17 | 16.14 | 14.91 | 18.23 | 24.44 | 24.85 | 15.11 | 8.96 | 9.86 | 12.75 | 17.18 |
| PER(x) | 0 | 0 | 24.14 | 16.93 | 8.68 | 14.64 | 21.17 | 16.82 | 42.17 | 169.73 | 29.16 |
| Price/Book(x) | 0 | 0 | 6.32 | 2.9 | 1.33 | 1.47 | 1.86 | 1.23 | 1.24 | 1.33 | 2.15 |
| Dividend Yield(%) | 0 | 0 | 0.33 | 0.61 | 1.19 | 0.96 | 0.9 | 1.3 | 1.02 | 0.95 | 0.69 |
| EV/Net Sales(x) | 0.17 | 0.19 | 1.93 | 1.29 | 0.81 | 0.98 | 1.11 | 0.64 | 0.89 | 0.89 | 1.2 |
| EV/Core EBITDA(x) | 2.25 | 2.36 | 14.86 | 10.18 | 6.29 | 8.19 | 11.16 | 8.06 | 16.36 | 24.4 | 15.37 |
| Net Sales Growth(%) | 0.7 | 15.77 | 42.93 | -12.41 | -5.44 | -1.04 | 13.16 | 15.56 | -24.87 | 1.18 | 14.45 |
| EBIT Growth(%) | 6.98 | 21.07 | 149.2 | -17.35 | -8.8 | -16.28 | -3.83 | -11.21 | -55.77 | -50.19 | 299.54 |
| PAT Growth(%) | 5.03 | 30.33 | 214.81 | -23.14 | -0.25 | -26.97 | -7.25 | -12.66 | -59.3 | -73.45 | 902.1 |
| EPS Growth(%) | 0 | 0 | 0 | -23.14 | -0.25 | -26.97 | -7.25 | -12.66 | -59.3 | -73.45 | 902.11 |
| Debt/Equity(x) | 1.05 | 1.01 | 0.28 | 0.3 | 0.37 | 0.38 | 0.36 | 0.18 | 0.22 | 0.15 | 0.01 |
| Current Ratio(x) | 1.28 | 1.36 | 2.45 | 1.82 | 1.62 | 2.04 | 2.36 | 2.93 | 3.01 | 3.39 | 5.96 |
| Quick Ratio(x) | 0.62 | 0.91 | 1.59 | 1.09 | 0.73 | 1.19 | 1.21 | 1.37 | 1.4 | 1.6 | 2.84 |
| Interest Cover(x) | 3.86 | 4.34 | 13.94 | 15.3 | 8.59 | 4.81 | 4.23 | 4.44 | 3.09 | 1.64 | 12.79 |
| Total Debt/Mcap(x) | 0 | 0 | 0.04 | 0.1 | 0.28 | 0.26 | 0.19 | 0.15 | 0.17 | 0.11 | 0.01 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 |
| FII | 0 | 1.27 | 2.43 | 3.36 | 3.29 | 4.18 | 4.84 | 4.74 | 6 | 5.83 |
| DII | 0.05 | 0.22 | 0.76 | 0.37 | 0.44 | 0.55 | 0.55 | 0.55 | 0.66 | 0.61 |
| Public | 27.33 | 25.88 | 24.19 | 23.65 | 23.66 | 22.64 | 21.98 | 22.08 | 20.73 | 20.93 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 |
| FII | 0 | 0.04 | 0.08 | 0.11 | 0.1 | 0.13 | 0.15 | 0.15 | 0.19 | 0.18 |
| DII | 0 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 0.85 | 0.81 | 0.76 | 0.74 | 0.74 | 0.71 | 0.69 | 0.69 | 0.65 | 0.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +14% | -5% | +3% | +4% |
| Operating Profit CAGR | +143% | -5% | -6% | +5% |
| PAT CAGR | +875% | +3% | -2% | +7% |
| Share Price CAGR | +44% | +13% | +2% | — |
| ROE Average | +8% | +4% | +6% | +15% |
| ROCE Average | +10% | +6% | +8% | +17% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 |
| FII | 0 | 1.27 | 2.43 | 3.36 | 3.29 | 4.18 | 4.84 | 4.74 | 6 | 5.83 |
| DII | 0.05 | 0.22 | 0.76 | 0.37 | 0.44 | 0.55 | 0.55 | 0.55 | 0.66 | 0.61 |
| Public | 27.33 | 25.88 | 24.19 | 23.65 | 23.66 | 22.64 | 21.98 | 22.08 | 20.73 | 20.93 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 |
| FII | 0 | 0.04 | 0.08 | 0.11 | 0.1 | 0.13 | 0.15 | 0.15 | 0.19 | 0.18 |
| DII | 0 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 0.85 | 0.81 | 0.76 | 0.74 | 0.74 | 0.71 | 0.69 | 0.69 | 0.65 | 0.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.